Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.
about
Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) QuestionnaireClinical outcomes in psoriatic arthritis: A systematic literature reviewQuality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011.Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics RegisterSpondyloarthritides: evolving therapiesHealth state utility values in patients undergoing endoscopic sinus surgery.Evaluation of some psychological factors in psoriatic patientsComparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional studyDrug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis.Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), ChecTreatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety.Patient-Reported Outcomes in Psoriatic Arthritis.Comparative effectiveness of biologic therapies on improvements in quality of life in patients with psoriasis.Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature.
P2860
Q21133692-D66CA352-5895-44E4-AD9A-35B7C5FDFFA0Q26995307-257298AB-2F85-473C-B616-7BCC8E6C6DCAQ30584293-EFF9C748-3C36-4D16-AEEC-6C163E3B72E7Q33726924-D0A776F4-70FC-4106-8F89-947F9B5DB415Q34613907-B0C420CA-7B23-4E3B-AE5F-82088EA41F27Q35596345-EDBD32C6-0228-400E-9A19-32DFDD4A0912Q35615027-A06AA52C-F51A-4474-A789-635258827F69Q36033361-DEA1DDC0-DD7F-482A-A11F-C0C29CB99369Q36422360-1C6FAC5B-9034-4EA2-8876-8439ED58BB1FQ37826195-35B58329-CC00-4EB7-AF72-6FD099D8BD34Q37929647-90D71CCB-8A99-4A84-B1D7-44C2E7E899B4Q38010362-E6212126-4B03-442D-9E93-E749FB609E6FQ38204241-CA5E9EF4-C589-46F1-A7D5-AABD2EA1E9C8Q38822369-3CFB5D42-6D35-4C24-A28E-140D8C0D1F1DQ40261663-8676501A-9DBC-4774-8EF4-5D0964DBEE26Q42293363-89FF6E58-ED62-4E97-A4A9-062616D1A528Q55397612-C85119E9-B0D0-4884-8B10-C45827856E4E
P2860
Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Improvements in quality of lif ...... mor necrosis factor therapies.
@ast
Improvements in quality of lif ...... mor necrosis factor therapies.
@en
Improvements in quality of lif ...... mor necrosis factor therapies.
@nl
type
label
Improvements in quality of lif ...... mor necrosis factor therapies.
@ast
Improvements in quality of lif ...... mor necrosis factor therapies.
@en
Improvements in quality of lif ...... mor necrosis factor therapies.
@nl
prefLabel
Improvements in quality of lif ...... mor necrosis factor therapies.
@ast
Improvements in quality of lif ...... mor necrosis factor therapies.
@en
Improvements in quality of lif ...... mor necrosis factor therapies.
@nl
P2093
P2860
P356
P1476
Improvements in quality of lif ...... mor necrosis factor therapies.
@en
P2093
Amr A Saad
British Society for Rheumatology Biologics Register
Deborah P M Symmons
Kath D Watson
Kimme L Hyrich
Peter R Noyce
P2860
P304
P356
10.1002/ACR.20104
P577
2010-03-01T00:00:00Z